tm logo
CAMBIUM CELL
Live/Registered
REGISTERED

on 14 May 2019

Last Applicant/ Owned by

10326 Aldea Avenue

Granada Hills

CA

91344

Serial Number

88166252 filed on 23rd Oct 2018

Registration Number

5753713 registered on 14th May 2019

in the Supplemental Register

Correspondent Address

GRANDA HILLS, CA 91344

UNITED STATES

Filing Basis

1. filed as use application

2. use application currently

Disclaimer

NO DATA

CAMBIUM CELL

Biotechnology research; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Research and development in the pharmaceutical and biotechnology fields

Classification Information


Class [042]
Computer & Software Services & Scientific Services


Biotechnology research; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Research and development in the pharmaceutical and biotechnology fields


First Use Date in General

22nd Oct 2018

First Use Date in Commerce

22nd Oct 2018

Mark Details


Serial Number

No 88166252

Mark Type

No Service Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
14th May 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
14th May 2019REGISTERED-SUPPLEMENTAL REGISTER
05th Apr 2019LAW OFFICE PUBLICATION REVIEW COMPLETED
02th Apr 2019APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
04th Mar 2019TEAS/EMAIL CORRESPONDENCE ENTERED
04th Mar 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
04th Mar 2019ASSIGNED TO LIE
27th Feb 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
06th Feb 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
06th Feb 2019NON-FINAL ACTION E-MAILED